We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

77 hedge funds and large institutions have $384M invested in Coherus Oncology in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

19% more capital invested

Capital invested by funds: $322M → $384M (+$61.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

1% less funds holding

Funds holding: 78 → 77 (-1)

55% less call options, than puts

Call options by funds: $122K | Put options by funds: $272K

Holders
77
Holders Change
-1
Holders Change %
-1.28%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
30
Reduced
23
Closed
16
Calls
$122K
Puts
$272K
Net Calls
-$150K
Net Calls Change
+$1.32M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$34.4M
2
BFA
BlackRock Fund Advisors
California
+$12.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$7.24M
4
TA
Teachers Advisors
New York
+$2.38M
5
IHM
Iguana Healthcare Management
New York
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
TCP
Tourbillon Capital Partners
New York
-$15.7M
2
VM
VHCP Management
New York
-$6.67M
3
RFC
Russell Frank Company
Washington
-$4.54M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$3.25M
5
Fidelity International
Fidelity International
Bermuda
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.13M +$84.7K +3,291 +4%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.9M -$39.8K -1,547 -2%
BIM
28
BlackRock Investment Management
Delaware
$1.89M +$566 +22 +0%
NI
29
Numeric Investors
Massachusetts
$1.86M -$3.12M -121,148 -60%
IHM
30
Iguana Healthcare Management
New York
$1.72M +$1.93M +75,000 New
RFC
31
Russell Frank Company
Washington
$1.29M -$4.54M -176,581 -76%
Charles Schwab
32
Charles Schwab
California
$1.15M +$21.7K +845 +2%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$1M +$17.7K +689 +2%
ProShare Advisors
34
ProShare Advisors
Maryland
$797K +$893K +34,708 New
AllianceBernstein
35
AllianceBernstein
Tennessee
$783K – – –
CS
36
Credit Suisse
Switzerland
$780K +$873K +33,929 New
AAMU
37
AEGON Asset Management (UK)
United Kingdom
$719K +$806K +31,338 New
Franklin Resources
38
Franklin Resources
California
$574K – – –
Swiss National Bank
39
Swiss National Bank
Switzerland
$540K +$144K +5,600 +31%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$533K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$516K +$43.9K +1,705 +8%
SAM
42
Sectoral Asset Management
Quebec, Canada
$366K -$14.4K -558 -3%
NFA
43
Nationwide Fund Advisors
Ohio
$355K +$5.53K +215 +1%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$328K +$368K +14,300 New
HI
45
Handelsinvest Investeringsforvaltning
Denmark
$326K +$365K +14,200 New
AIG
46
American International Group
New York
$317K -$618 -24 -0.2%
UBS AM
47
UBS AM
Illinois
$264K +$296K +11,499 New
Squarepoint
48
Squarepoint
New York
$246K +$275K +10,700 New
VOYA Investment Management
49
VOYA Investment Management
Georgia
$210K +$235K +9,128 New
Wells Fargo
50
Wells Fargo
California
$205K +$108K +4,195 +89%
1
2
3 4

CHRS Hedge Fund Activity: Q4 2015 in Review

77 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2015, worth a combined $384M — up 19% from $322M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of CHRS and 15 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 30 added.

The largest buyer was Fidelity Investments, adding an estimated $34.4M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $15.7M sold.

  • 77 institutional investors held Coherus Oncology (CHRS) as of Q4 2015, down from 78 in Q3 2015.
  • Funds reported $384M of Coherus Oncology stock for Q4 2015, up 19% quarter-over-quarter.
  • 15 funds opened new Coherus Oncology positions in Q4 2015 and 16 closed out, a net change of -1 holder.
  • The largest Coherus Oncology buyer in Q4 2015 was Fidelity Investments, an estimated $34.4M added.
  • The largest Coherus Oncology seller in Q4 2015 was Tourbillon Capital Partners, an estimated $15.7M sold.

Based on aggregated 13F filings for Q4 2015.